Indian households are shifting their savings from traditional bank deposits to alternative assets like property and equities, driven by easier access to retail loans and a younger, tech-savvy population. This trend has led to a decline in bank deposit growth, with credit growth outpacing deposits, prompting concerns about monetary policy effectiveness. As the Reserve Bank of India is expected to cut rates, challenges persist due to asymmetric monetary transmission and reduced liquidity from government cash management measures.
14:58 18.10.2024
A study led by Dr. Benjamin C. James reveals that cancer diagnoses can lead to significant long-term financial challenges, including higher rates of bankruptcy and lower credit scores. Patients with cancer are nearly five times more likely to declare bankruptcy, with credit scores averaging 80 points lower than non-cancer patients. Factors such as age, race, marital status, and income level contribute to the severity of financial toxicity, highlighting the need for policy reforms in cancer care.
Cancer patients face significant financial challenges, with nearly five times the bankruptcy rate and average credit scores nearly 80 points lower than non-cancer patients. Research from Beth Israel Deaconess Medical Center highlights that financial toxicity persists for years post-diagnosis, particularly affecting those under 62, minorities, and individuals with lower incomes. These findings underscore the need for policy reforms to address the financial burdens associated with cancer care.
The U.S. economic surprise index has surged, driven by strong retail sales and improved jobless claims, leading to a sharp rise in the 10-year yield and the Dollar Index. However, despite a favorable economic outlook and rising Trump poll numbers fueling market optimism, the SP500's high valuation raises concerns about potential risks from prolonged high rates and fiscal deficits.
IG
14:19 18.10.2024
Gilead has withdrawn its bladder cancer treatment Trodelvy after a confirmatory study failed to demonstrate improved survival rates. Initially granted accelerated approval in 2021, the decision reflects the FDA's increased scrutiny of such approvals. Despite this setback, Trodelvy remains a key player in Gilead's oncology portfolio, particularly for breast cancer, where sales are projected to reach $1 billion by 2030.
Intelsat and Softbank are advancing toward a universal 5G broadband terminal that integrates satellite and terrestrial communications for global connectivity. This initiative follows the approval of Ku-band satellite spectrum for 5G standards and aims to provide seamless service across various markets, including automotive and military. While full standardization may take a few years, Intelsat hints at potential hybrid solutions that could be deployed as early as next year.
Helius Medical Technologies, Inc. will present at the ThinkEquity Conference on October 30, 2024, at the Mandarin Oriental Hotel in New York, focusing on its innovative neuromodulation approach for balance and gait deficits. Management is scheduled to present at 4:30 PM ET and will hold one-on-one investor meetings throughout the day. The company is known for its Portable Neuromodulation Stimulator, aimed at improving the lives of those with neurologic diseases.
Datadog's CFO sold shares at an average price of $125.70, totaling over $4.18 million, while retaining 314,158 shares valued at approximately $39.49 million. In the past three months, insiders sold 529,928 shares worth $63.08 million, with corporate insiders owning 11.78% of the stock. Institutional investors hold 78.29% of Datadog, which has received multiple upgrades from analysts, now holding a "Moderate Buy" rating with a price target averaging $142.11.
13:46 18.10.2024
The HLTH 2024 conference in Las Vegas will gather 12,000 attendees, including leaders from health systems, payers, and digital health startups, to discuss healthcare innovation. Key topics include AI's role in healthcare, the future of retail health, women's mental health, and advancements in healthy aging and brain health. Notable speakers include executives from major companies like Johnson & Johnson, Amazon, and Pfizer, alongside policymakers addressing the regulatory landscape.
Stay updated on the latest developments in biotech stocks, including pharmaceutical companies and drug manufacturers. This sector is dynamic, with ongoing news that can impact investment decisions. Keep an eye on emerging trends and breakthroughs in the industry.
Trending
Subcategory:
Countries:
Companies:
Currencies:
People:

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings